Skip to content

Clinical trials

Phase 2 Multiple Sclerosis trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Sclerosis Phase: Phase 2 Country / region: Netherlands Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20061
20071
20091
20101
20112
20121
20131
20141
20151
20171
20211
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Terminated3
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Biogen4
Actelion2
GlaxoSmithKline2
AbbVie (prior sponsor, Abbott)1
Academic MS Center Limburg1
Immunic AG1
Merck KGaA, Darmstadt, Germany1
Teva Branded Pharmaceutical Products R&D, Inc.1
UCB Pharma1
University Medical Center Groningen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Sclerosis16
Multiple Sclerosis, Chronic Progressive2
Multiple Sclerosis, Relapsing-Remitting2
Amyotrophic Lateral Sclerosis1
Major Depressive Disorder1
Pulmonary Disease, Chronic Obstructive1
Sleep Initiation and Maintenance Disorders1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.